Obesity, overweight, and hypertension could also affect the risk of retinopathy if not managed in patients. The Swedish National Diabetes Register was used to conduct the study and collect data on ...

Ripasudil hydrochloride hydrate is under clinical development by Kowa and currently in Phase II for Retinopathy Of Prematurity.